COGTCogent Biosciences, Inc.
$31.02+159% 1Y
$31.02
$12.5152 weeks$42.84
The financials
Cogent Biosciences, Inc. by the numbers
The next results filing is expected around Nov 2, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$103M | −$76M | n/a |
| Net income | −$96M | −$74M | n/a |
| Diluted EPS | −$0.52 | −$0.53 | n/a |
On our screens:Most shorted stocks